Tobacco Products

"Covered" Tobacco Products and Roll-Your-Own/ Cigarette Tobacco Labeling and Warning Statement Requirements


On this page:


Required Warning Statements

The United States District Court for the District of Columbia recently issued an order enjoining FDA from enforcing the health warnings requirements for cigars and pipe tobacco set forth in 21 CFR §§ 1143.3 and 1143.5 until 60 days after final disposition of the plaintiffs’ appeal of the court’s order on the health warnings requirements. See Order, Cigar Ass’n of Am. v. U.S. Food & Drug Admin., No. 1:16-cv-01460 (D.D.C. July 5, 2018). The compliance date for the health warnings requirements in 21 CFR part 1143 is August 10, 2018. FDA intends to comply with the court’s order in Cigar Association of America. In addition, the agency does not intend to enforce the labeling requirements under sections 903(a)(2) and 920(a)(1) for cigars and pipe tobacco while the injunction is in effect so that firms may make these required label changes at one time. See 81 Fed. Reg. at 29,006 (noting that compliance date for the 903(a)(2) and 920(a)(1) requirements is intended to match date for health warnings). We note that cigar and pipe tobacco firms may choose to voluntarily comply with 21 CFR §§ 1143.3 and 1143.5 and sections 903(a)(2) and 920(a)(1) while the injunction is in effect. Below we are describing certain provisions relating to the health warning requirements for covered tobacco products (other than cigars), RYO tobacco, and cigarette tobacco as set forth in the deeming rule. For pipe tobacco, this description is intended to assist firms with voluntary compliance since, as noted, the health warning requirements for pipe tobacco will not be enforced while the injunction is in effect. For more information, see new guidance: Compliance Policy for Certain Labeling and Warning Statement Requirements for Cigars and Pipe Tobacco.

The court’s order does not enjoin FDA from enforcing the health warning requirements for other product categories, including Electronic Nicotine Delivery Systems (ENDS) products, hookah tobacco, and cigarette tobacco and roll-your-own tobacco products.

A “covered tobacco product” is any tobacco product deemed under the deeming final rule to be subject to chapter IX of the Federal Food, Drug, and Cosmetic Act, but excludes any component or part that is not made or derived from tobacco. For example, cigars, liquid nicotine, hookah/waterpipe tobacco, and pipe tobacco would be considered “covered tobacco products,” while vaporizers or pipes that are not pre-loaded with tobacco or a tobacco-derived substance would not.

By the compliance date of August 10, 2018, roll-your-own tobacco, cigarette tobacco, or covered tobacco products (except cigars and pipe tobacco) manufactured, packaged, sold, offered for sale, distributed, or imported for sale or distribution within the United States must bear the required warning statement on the tobacco product package label, per 21 CFR § 1143.3(a)(1).1 (Cigar required warnings are described under 21 CFR § 1143.5.) 
 

"WARNING: This product contains nicotine. Nicotine is an addictive chemical."


This required warning statement must also meet certain requirements, with respect to font, text, size, placement and formatting of the warning statement on the package labels. That is, the required warning statement on package labels must also appear directly on the package, and be clearly visible underneath any cellophane or other clear wrapping, per 21 CFR § 1143.3(a)(2), as follows:

  • Be located in a conspicuous and prominent place on the two "principal display panels" of the package;
  • Comprise at least 30 percent of each of the principal display panels;
  • Be printed in at least 12-point font size and must occupy the greatest possible proportion of the warning label area set aside for the required text;
  • Be printed in conspicuous and legible Helvetica bold or Arial bold type or other similar sans serif fonts and in black text on a white background or white text on a black background in a manner that contrasts by typography, layout, or color, with all other printed material on the package;
  • Be capitalized and punctuated as indicated in 21 CFR § 1143.3(a)(1); and
  • Be centered in the warning area in which the text is required to be printed and positioned such that the text of the required warning statement and the other information on the principal display panels have the same orientation.

A retailer of any cigarette tobacco, roll-your-own tobacco, or covered tobacco products (other than cigars) will not be in violation of this section for packaging that: (i) Contains a health warning; (ii) Is supplied to the retailer by the tobacco product manufacturer, importer, or distributor, who has the required state, local, or Alcohol and Tobacco Tax and Trade Bureau (TTB)-issued license or permit, if applicable; and (iii) Is not altered by the retailer in a way that is material to the requirements of this section.

Roll-your-own tobacco packaging

Roll-your-own tobacco packaging

Pipe tobacco packaging

E-liquid bottle packaging

These images are intended to serve as examples and alternative approaches may suffice.


Packages that are Too Small to Display the Required Warning Statement

A covered tobacco product (other than cigars), cigarette tobacco product, or roll-your-own tobacco product that is too small or otherwise unable to accommodate a label with sufficient space to bear the required warning statement must contain the required warning statement on one of the following, per 21 CFR § 1143.3(d):

  • Carton
  • Outer container
  • Wrapper
  • Tag firmly and permanently affixed to the tobacco product package.

E-liquid bottle packaging front and back views

These images are intended to serve as examples and alternative approaches may suffice.


Zero-Nicotine: Self-certification and Alternative Required Warning Statement

If the product does not contain nicotine and is made or derived from tobacco, the tobacco product manufacturer may display the alternative statement, instead of the nicotine addictiveness warning statement.

To display the alternative statement on packages and/or advertisements for a tobacco product, the tobacco product manufacturer must submit to FDA a confirmation statement certifying to be true and accurate that the product does not contain nicotine and that the tobacco product manufacturer has data to support that assertion. If you have any questions on the self-certification, you can contact FDA.

The alternative warning statement, under 21 CFR § 1143.3(c), for applicable package labels and advertisements reads:

This product is made from tobacco.

 

Tobacco products that do not contain tobacco or nicotine and are not made or derived from tobacco or nicotine do not meet the definition of covered tobacco product, and will not be required to carry an addiction warning or to submit a self-certification for use of the alternative statement.


Other Labeling Requirements

There are other labeling requirements. For example, tobacco products deemed under the deeming final rule to be subject to FDA’s authority, if in package form, must bear a label containing —

  • the name and place of business of the tobacco product manufacturer, packer, or distributor;
  • an accurate statement of the quantity of the contents in terms of weight, measure, or numerical count;
  • an accurate statement of the percentage of the tobacco used in the product that is domestically grown tobacco and the percentage that is foreign grown tobacco; and
  • the statement required under section 920(a)…(section 903(a)(2) of the Federal Food, Drug, and Cosmetic Act (FD&C Act)).

Section 920(a) of the FD&C Act provides that the label, packaging, and shipping containers of tobacco products shall bear the statement “Sale only allowed in the United States”.

In the draft guidance, entitled, “Interpretation of and Compliance Policy for Certain Label Requirement; Applicability of Certain Federal Food, Drug, and Cosmetic Act Requirements to Vape Shops”, FDA indicated that it does not intend to enforce section 903(a)(2)(C) of the FD&C Act for those products that are made or derived from tobacco. When the draft guidance is finalized it will represent FDA’s current thinking on the issues contained therein.


1. FDA does not intend to enforce these warning statement requirements for products that were manufactured before the compliance date (August 10, 2018) of the new required warning statement for covered tobacco products, cigarette tobacco, and RYO tobacco. For important details about required warning statements, please see the small entity compliance guide.


 

Page Last Updated: 08/13/2018
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English